[Form 4] IONIS PHARMACEUTICALS INC Insider Trading Activity
Rhea-AI Filing Summary
HANTSON LUDWIG reported acquisition or exercise transactions in this Form 4 filing.
Ionis Pharmaceuticals director Ludwig Hantson received a grant of 3,399 Restricted Stock Units on July 15, 2026 under the Ionis Pharmaceuticals, Inc. Amended and Restated 2002 Non-Employee Directors' Stock Option Plan. Each RSU is a contingent right to one share of common stock or its cash value, vesting in three equal annual installments from July 15, 2027 and fully vesting on July 15, 2029. As of the grant date, 0 RSUs were vested and he holds 3,399 RSUs in total.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
HANTSON LUDWIG
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Unit | 3,399 | $0.00 | -- |
Holdings After Transaction:
Restricted Stock Unit — 3,399 shares (Direct)
Footnotes (1)
- Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value. Grant on July 15, 2026 to reporting person of Restricted Stock Unit Award under the Ionis Pharmaceuticals, Inc. Amended and Restated 2002 Non-Employee Directors' Stock Option Plan. Restricted Stock Units vest in three equal annual installments, the first installment vesting on July 15, 2027. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company. The RSU shall be fully vested on July 15, 2029. The RSU is vested as to 0 shares on July 15, 2026.
Key Figures
Restricted Stock Units granted: 3,399 units
Underlying common shares per RSU: 1 share per unit
Vesting installments: 3 annual installments
+3 more
6 metrics
Restricted Stock Units granted
3,399 units
Grant to director Ludwig Hantson on July 15, 2026
Underlying common shares per RSU
1 share per unit
Each RSU is a contingent right to one share of Ionis common stock
Vesting installments
3 annual installments
RSUs vest in three equal annual installments starting July 15, 2027
Full vesting date
July 15, 2029
RSUs shall be fully vested on July 15, 2029
RSUs vested at grant
0 units
RSUs are vested as to 0 shares on July 15, 2026
Total RSUs after grant
3,399 units
Total restricted stock units held directly following the reported award
Key Terms
Restricted Stock Unit, contingent right, Amended and Restated 2002 Non-Employee Directors' Stock Option Plan
3 terms
Restricted Stock Unit financial
"Grant on July 15, 2026 to reporting person of Restricted Stock Unit Award"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
contingent right financial
"Each Restricted Stock Unit represents a contingent right to receive one share"
Amended and Restated 2002 Non-Employee Directors' Stock Option Plan financial
"under the Ionis Pharmaceuticals, Inc. Amended and Restated 2002 Non-Employee Directors' Stock Option Plan"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did Ionis Pharmaceuticals (IONS) report for Ludwig Hantson?
Ionis reported that director Ludwig Hantson received a grant of 3,399 Restricted Stock Units (RSUs) on July 15, 2026. The award was made under the company’s Amended and Restated 2002 Non-Employee Directors' Stock Option Plan and is payable in stock or cash upon vesting.
How many Restricted Stock Units did Ludwig Hantson receive in the IONS Form 4 filing?
Ludwig Hantson received 3,399 Restricted Stock Units from Ionis Pharmaceuticals. These RSUs correspond to 3,399 underlying shares of Ionis common stock, subject to vesting conditions, and result in total direct holdings of 3,399 RSUs immediately after the grant.
What is the vesting schedule for Ludwig Hantson's 3,399 Ionis (IONS) Restricted Stock Units?
The 3,399 RSUs vest in three equal annual installments beginning July 15, 2027. The award becomes fully vested on July 15, 2029, with 0 RSUs vested as of the July 15, 2026 grant date, according to the plan’s terms.
What does each Restricted Stock Unit represent in Ludwig Hantson's Ionis (IONS) award?
Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock or its equivalent cash value. Upon vesting, the RSUs will be paid out in whole shares or cash, as determined by Ionis Pharmaceuticals.
Under which equity plan were Ludwig Hantson's Ionis (IONS) RSUs granted?
The RSUs were granted under the Ionis Pharmaceuticals, Inc. Amended and Restated 2002 Non-Employee Directors' Stock Option Plan. This plan provides equity-based compensation to non-employee directors, including Restricted Stock Unit awards like Hantson’s grant.
How many Restricted Stock Units does Ludwig Hantson hold after this Ionis (IONS) grant?
Following the reported transaction, Ludwig Hantson holds 3,399 Restricted Stock Units. As of the July 15, 2026 grant date, the RSUs are vested as to 0 shares, with vesting beginning in 2027 and completing in 2029.